Skip to content
Vectorb2b
  • Home
  • About us
    • Governance
    • Our team
    • Careers
  • Services
    • Discovery
    • Toxicology
    • Chemistry Manufacturing
    • Clinical Services
    • Functional Service Providing
    • R&D Portfolio Management Services
    • Integrated Solutions
  • Articles
  • News
  • Contacts
  • Home
  • About us
    • Governance
    • Our team
    • Careers
  • Services
    • Discovery
    • Toxicology
    • Chemistry Manufacturing
    • Clinical Services
    • Functional Service Providing
    • R&D Portfolio Management Services
    • Integrated Solutions
  • Articles
  • News
  • Contacts

Preclinical

Glaucoma: evaluating retinal protection in preclinical models

How preclinical models support glaucoma research and the evalua-tion of retinal protection

Add excerpt here

Diabetic retinopathy: evaluating therapeutic strategies in preclinical models

Diabetic retinopathy case study: evaluating retinal damage and therapeutic responses in preclinical models

Add excerpt here

GLP toxicology requirements: when are studies needed in drug development?

GLP toxicology requirements across different stages of drug development

Add excerpt here

How do ÄKTA chromatography systems support recombinant protein purification?

Recombinant protein purification with ÄKTA™ systems

Add excerpt here

Building a drug development consortium for greater funding competitiveness and health innovation

How can building a drug development consortium strengthen funding, execution and regulatory readiness?

Add excerpt here

In vivo phage display: advancing antibody selection for targeted drug development

How can in vivo phage display support antibody selection and targeted drug development?

Add excerpt here

In vivo models in retinal research: bridging pathophysiology and translational development

How do in vivo models in retinal research bridge pathophysiology and translational development?

Add excerpt here

Xenograft models in cancer research: principles and applications in preclinical oncology

The principles and applications of xenograft models in preclinical oncology research

Add excerpt here

GLP toxicology studies in rodents: a critical foundation for the development of new compounds

GLP toxicology studies in rodents: a critical foundation for the development of new compounds

Add excerpt here

Artigos recentes

  • Glaucoma: evaluating retinal protection in preclinical models
  • Grant writing tips for pharma and biotech: how to build a competitive funding proposal
  • Diabetic retinopathy: evaluating therapeutic strategies in preclinical models
  • GLP toxicology requirements: when are studies needed in drug development?
  • Building a regulatory strategy for clinical development: avoiding the most common mistakes

Comentários recentes

No comments to show.
Vector B2B

Follow Us

Quick access
  • Discovery
  • Toxicology
  • Manufacturing Services
  • Clinical Services
  • Integrated Solutions
  • Careers
Contacts

Avenida da Liberdade, 258, 6.º 1250-149 Lisboa Portugal

+351 210 976 863

info@vectorb2b.com

  • Copyright © 2026
  • All rights reserved
  • Privacy policy